1、Obata H. Anatomy and histopathology of human meibomian gland. Cornea. 2002, 21(7 Suppl): S70-S74. DOI: 10.1097/01.ico.0000263122.45898.09. Obata H. Anatomy and histopathology of human meibomian gland. Cornea. 2002, 21(7 Suppl): S70-S74. DOI: 10.1097/01.ico.0000263122.45898.09.
2、Butovich IA. Meibomian glands, meibum, and meibogenesis. Exp Eye Res. 2017, 163: 2-16. DOI: 10.1016/j.exer.2017.06.020. Butovich IA. Meibomian glands, meibum, and meibogenesis. Exp Eye Res. 2017, 163: 2-16. DOI: 10.1016/j.exer.2017.06.020.
3、Knop E, Knop N, Millar T, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011, 52(4): 1938-1978. DOI: 10.1167/iovs.10-6997c.Knop E, Knop N, Millar T, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011, 52(4): 1938-1978. DOI: 10.1167/iovs.10-6997c.
4、Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016, 100(3): 300-306. DOI: 10.1136/bjophthalmol-2015-307415. Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016, 100(3): 300-306. DOI: 10.1136/bjophthalmol-2015-307415.
5、Arita R, Itoh K, Inoue K, et al. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008, 115(5): 911-915. DOI: 10.1016/j.ophtha.2007.06.031. Arita R, Itoh K, Inoue K, et al. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008, 115(5): 911-915. DOI: 10.1016/j.ophtha.2007.06.031.
6、Villani E, Canton V, Magnani F, et al. The aging Meibomian gland: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2013, 54(7): 4735-4740. DOI: 10.1167/iovs.13-11914. Villani E, Canton V, Magnani F, et al. The aging Meibomian gland: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2013, 54(7): 4735-4740. DOI: 10.1167/iovs.13-11914.
7、Viso E, Rodríguez-Ares MT, Abelenda D, et al. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci, 2012, 53(6): 2601-2606. DOI: 10.1167/iovs.11-9228. Viso E, Rodríguez-Ares MT, Abelenda D, et al. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci, 2012, 53(6): 2601-2606. DOI: 10.1167/iovs.11-9228.
8、Uchino M, Dogru M, Yagi Y, et al. The features of dry eye disease in a Japanese elderly population. Optom Vis Sci. 2006, 83(11): 797-802. DOI: 10.1097/01.opx.0000232814.39651.fa.Uchino M, Dogru M, Yagi Y, et al. The features of dry eye disease in a Japanese elderly population. Optom Vis Sci. 2006, 83(11): 797-802. DOI: 10.1097/01.opx.0000232814.39651.fa.
9、Moreno I, Verma S, Gesteira TF, et al. Recent advances in age-related meibomian gland dysfunction (ARMGD). Ocul Surf. 2023, 30: 298-306. DOI: 10.1016/j.jtos.2023.11.003. Moreno I, Verma S, Gesteira TF, et al. Recent advances in age-related meibomian gland dysfunction (ARMGD). Ocul Surf. 2023, 30: 298-306. DOI: 10.1016/j.jtos.2023.11.003.
10、Asiedu K, Dzasimatu S, Kyei S. Impact of meibomian gland dysfunction on quality of life and mental health in a clinical sample in Ghana: a cross-sectional study. BMJ Open. 2022, 12(9): e061758. DOI: 10.1136/bmjopen-2022-061758. Asiedu K, Dzasimatu S, Kyei S. Impact of meibomian gland dysfunction on quality of life and mental health in a clinical sample in Ghana: a cross-sectional study. BMJ Open. 2022, 12(9): e061758. DOI: 10.1136/bmjopen-2022-061758.
11、Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017, 124(11S): S20-S26. DOI: 10.1016/j.ophtha.2017.05.031. Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017, 124(11S): S20-S26. DOI: 10.1016/j.ophtha.2017.05.031.
12、Jester JV, Parfitt GJ, Brown DJ. Meibomian gland dysfunction: hyperkeratinization or atrophy. BMC Ophthalmol. 2015, 15(Suppl 1): 156. DOI: 10.1186/s12886-015-0132-x.Jester JV, Parfitt GJ, Brown DJ. Meibomian gland dysfunction: hyperkeratinization or atrophy. BMC Ophthalmol. 2015, 15(Suppl 1): 156. DOI: 10.1186/s12886-015-0132-x.
13、Xu KK, Huang YK, Liu X, et al. Organotypic culture of mouse meibomian gland: a novel model to study meibomian gland dysfunction in vitro. Invest Ophthalmol Vis Sci. 2020, 61(4): 30. DOI: 10.1167/iovs.61.4.30. Xu KK, Huang YK, Liu X, et al. Organotypic culture of mouse meibomian gland: a novel model to study meibomian gland dysfunction in vitro. Invest Ophthalmol Vis Sci. 2020, 61(4): 30. DOI: 10.1167/iovs.61.4.30.
14、Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000, 85(12): 4874-4882. DOI: 10.1210/jcem.85.12.7072.Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000, 85(12): 4874-4882. DOI: 10.1210/jcem.85.12.7072.
15、Golebiowski%20B%2C%20Badarudin%20N%2C%20Eden%20J%2C%20et%20al.%20Does%20endogenous%20serum%20oestrogen%20play%20a%20role%20in%20meibomian%20gland%20dysfunction%20in%20postmenopausal%20women%20with%20dry%20eye%3F%20Br%20J%20Ophthalmol.%202017%2C%20101(2)%3A%20218-222.%20DOI%3A%2010.1136%2Fbjophthalmol-2016-308473.Golebiowski%20B%2C%20Badarudin%20N%2C%20Eden%20J%2C%20et%20al.%20Does%20endogenous%20serum%20oestrogen%20play%20a%20role%20in%20meibomian%20gland%20dysfunction%20in%20postmenopausal%20women%20with%20dry%20eye%3F%20Br%20J%20Ophthalmol.%202017%2C%20101(2)%3A%20218-222.%20DOI%3A%2010.1136%2Fbjophthalmol-2016-308473.
16、Bu J, Zhang M, Wu Y, et al. High-fat diet induces inflammation of meibomian gland. Invest Ophthalmol Vis Sci. 2021, 62(10): 13. DOI: 10.1167/iovs.62.10.13. Bu J, Zhang M, Wu Y, et al. High-fat diet induces inflammation of meibomian gland. Invest Ophthalmol Vis Sci. 2021, 62(10): 13. DOI: 10.1167/iovs.62.10.13.
17、Cermak%20JM%2C%20Krenzer%20KL%2C%20Sullivan%20RM%2C%20et%20al.%20Is%20complete%20androgen%20insensitivity%20syndrome%20associated%20with%20alterations%20in%20the%20meibomian%20gland%20and%20ocular%20surface%3F%20Cornea.%202003%2C%2022(6)%3A%20516-521.%20DOI%3A%2010.1097%2F00003226-200308000-00006.%20Cermak%20JM%2C%20Krenzer%20KL%2C%20Sullivan%20RM%2C%20et%20al.%20Is%20complete%20androgen%20insensitivity%20syndrome%20associated%20with%20alterations%20in%20the%20meibomian%20gland%20and%20ocular%20surface%3F%20Cornea.%202003%2C%2022(6)%3A%20516-521.%20DOI%3A%2010.1097%2F00003226-200308000-00006.%20
18、Wang J, Liu Y, Kam WR, et al. Toxicity of the cosmetic preservatives parabens, phenoxyethanol and chlorphenesin on human meibomian gland epithelial cells. Exp Eye Res. 2020, 196: 108057. DOI: 10.1016/j.exer.2020.108057.Wang J, Liu Y, Kam WR, et al. Toxicity of the cosmetic preservatives parabens, phenoxyethanol and chlorphenesin on human meibomian gland epithelial cells. Exp Eye Res. 2020, 196: 108057. DOI: 10.1016/j.exer.2020.108057.
19、Nien CJ, Massei S, Lin G, et al. Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol. 2011, 129(4): 462-469. DOI: 10.1001/archophthalmol.2011.69.Nien CJ, Massei S, Lin G, et al. Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol. 2011, 129(4): 462-469. DOI: 10.1001/archophthalmol.2011.69.
20、Adil MY, Xiao J, Olafsson J, et al. Meibomian gland morphology is a sensitive early indicator of meibomian gland dysfunction. Am J Ophthalmol. 2019, 200: 16-25. DOI: 10.1016/j.ajo.2018.12.006. Adil MY, Xiao J, Olafsson J, et al. Meibomian gland morphology is a sensitive early indicator of meibomian gland dysfunction. Am J Ophthalmol. 2019, 200: 16-25. DOI: 10.1016/j.ajo.2018.12.006.
21、Suhalim JL, Parfitt GJ, Xie Y, et al. Effect of desiccating stress on mouse meibomian gland function. Ocul Surf. 2014, 12(1): 59-68. DOI: 10.1016/j.jtos.2013.08.002. Suhalim JL, Parfitt GJ, Xie Y, et al. Effect of desiccating stress on mouse meibomian gland function. Ocul Surf. 2014, 12(1): 59-68. DOI: 10.1016/j.jtos.2013.08.002.
22、Jester JV, Potma E, Brown DJ. PPARγ regulates mouse meibocyte differentiation and lipid synthesis. Ocul Surf. 2016, 14(4): 484-494. DOI: 10.1016/j.jtos.2016.08.001. Jester JV, Potma E, Brown DJ. PPARγ regulates mouse meibocyte differentiation and lipid synthesis. Ocul Surf. 2016, 14(4): 484-494. DOI: 10.1016/j.jtos.2016.08.001.
23、Qazi Y, Kheirkhah A, Blackie C, et al. Clinically relevant immune-cellular metrics of inflammation in meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2018, 59(15): 6111-6123. DOI: 10.1167/iovs.18-25571. Qazi Y, Kheirkhah A, Blackie C, et al. Clinically relevant immune-cellular metrics of inflammation in meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2018, 59(15): 6111-6123. DOI: 10.1167/iovs.18-25571.
24、Reyes NJ, Yu C, Mathew R, et al. Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice. Sci Transl Med. 2018, 10(451): eaas9164. DOI: 10.1126/scitranslmed.aas9164. Reyes NJ, Yu C, Mathew R, et al. Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice. Sci Transl Med. 2018, 10(451): eaas9164. DOI: 10.1126/scitranslmed.aas9164.
25、Bu J, Wu Y, Cai X, et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019, 17(4): 777-786. DOI: 10.1016/j.jtos.2019.06.002. Bu J, Wu Y, Cai X, et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019, 17(4): 777-786. DOI: 10.1016/j.jtos.2019.06.002.
26、Schr%C3%B6der%20A%2C%20Abrar%20DB%2C%20Hampel%20U%2C%20et%20al.%20In%20vitro%20effects%20of%20sex%20hormones%20in%20human%20meibomian%20gland%20epithelial%20cells.%20Exp%20Eye%20Res.%202016%2C%20151%3A%20190-202.%20DOI%3A%2010.1016%2Fj.exer.2016.08.009.Schr%C3%B6der%20A%2C%20Abrar%20DB%2C%20Hampel%20U%2C%20et%20al.%20In%20vitro%20effects%20of%20sex%20hormones%20in%20human%20meibomian%20gland%20epithelial%20cells.%20Exp%20Eye%20Res.%202016%2C%20151%3A%20190-202.%20DOI%3A%2010.1016%2Fj.exer.2016.08.009.
27、Butovich IA, Bhat N, Wojtowicz JC. Comparative transcriptomic and lipidomic analyses of human male and female meibomian glands reveal common signature genes of meibogenesis. Int J Mol Sci. 2019, 20(18): 4539. DOI: 10.3390/ijms20184539. Butovich IA, Bhat N, Wojtowicz JC. Comparative transcriptomic and lipidomic analyses of human male and female meibomian glands reveal common signature genes of meibogenesis. Int J Mol Sci. 2019, 20(18): 4539. DOI: 10.3390/ijms20184539.
28、Khandelwal P, Liu S, Sullivan DA. Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cells. Mol Vis. 2012, 18: 1055-1067. Khandelwal P, Liu S, Sullivan DA. Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cells. Mol Vis. 2012, 18: 1055-1067.
29、Schirra F, Richards SM, Liu M, et al. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res. 2006, 83(2): 291-296. DOI: 10.1016/j.exer.2005.11.026. Schirra F, Richards SM, Liu M, et al. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res. 2006, 83(2): 291-296. DOI: 10.1016/j.exer.2005.11.026.
30、Suzuki T, Schirra F, Richards SM, et al. Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci. 2008, 49(5): 1797-1808. DOI: 10.1167/iovs.07-1458.Suzuki T, Schirra F, Richards SM, et al. Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci. 2008, 49(5): 1797-1808. DOI: 10.1167/iovs.07-1458.
31、Suzuki T, Fujiwara S, Kinoshita S, et al. Cyclic change of fatty acid composition in meibum during the menstrual cycle. Invest Ophthalmol Vis Sci. 2019, 60(5): 1724-1733. DOI: 10.1167/iovs.18-26390. Suzuki T, Fujiwara S, Kinoshita S, et al. Cyclic change of fatty acid composition in meibum during the menstrual cycle. Invest Ophthalmol Vis Sci. 2019, 60(5): 1724-1733. DOI: 10.1167/iovs.18-26390.
32、Inaba T, Tanaka Y, Tamaki S, et al. Compensatory increases in tear volume and mucin levels associated with meibomian gland dysfunction caused by stearoyl-CoA desaturase-1 deficiency. Sci Rep. 2018, 8(1): 3358. DOI: 10.1038/s41598-018-21542-3. Inaba T, Tanaka Y, Tamaki S, et al. Compensatory increases in tear volume and mucin levels associated with meibomian gland dysfunction caused by stearoyl-CoA desaturase-1 deficiency. Sci Rep. 2018, 8(1): 3358. DOI: 10.1038/s41598-018-21542-3.
33、Sassa T, Tadaki M, Kiyonari H, et al. Very long-chain tear film lipids produced by fatty acid elongase ELOVL1 prevent dry eye disease in mice. FASEB J. 2018, 32(6): 2966-2978. DOI: 10.1096/fj.201700947R. Sassa T, Tadaki M, Kiyonari H, et al. Very long-chain tear film lipids produced by fatty acid elongase ELOVL1 prevent dry eye disease in mice. FASEB J. 2018, 32(6): 2966-2978. DOI: 10.1096/fj.201700947R.
34、Borchman D, Foulks GN, Yappert MC, et al. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci. 2011, 52(6): 3805-3817. DOI: 10.1167/iovs.10-6514. Borchman D, Foulks GN, Yappert MC, et al. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci. 2011, 52(6): 3805-3817. DOI: 10.1167/iovs.10-6514.
35、 Borchman D, Ramasubramanian A. Human meibum chain branching variability with age, gender and meibomian gland dysfunction. Ocul Surf. 2019, 17(2): 327-335. DOI: 10.1016/j.jtos.2018.12.005. Borchman D, Ramasubramanian A. Human meibum chain branching variability with age, gender and meibomian gland dysfunction. Ocul Surf. 2019, 17(2): 327-335. DOI: 10.1016/j.jtos.2018.12.005.
36、Kim SW, Xie Y, Nguyen PQ, et al. PPARγ regulates meibocyte differentiation and lipid synthesis of cultured human meibomian gland epithelial cells (hMGEC). Ocul Surf. 2018, 16(4): 463-469. DOI: 10.1016/j.jtos.2018.07.004. Kim SW, Xie Y, Nguyen PQ, et al. PPARγ regulates meibocyte differentiation and lipid synthesis of cultured human meibomian gland epithelial cells (hMGEC). Ocul Surf. 2018, 16(4): 463-469. DOI: 10.1016/j.jtos.2018.07.004.
37、Kim SW, Brown DJ, Jester JV. Transcriptome analysis after PPARγ activation in human meibomian gland epithelial cells (hMGEC). Ocul Surf. 2019, 17(4): 809-816. DOI: 10.1016/j.jtos.2019.02.003. Kim SW, Brown DJ, Jester JV. Transcriptome analysis after PPARγ activation in human meibomian gland epithelial cells (hMGEC). Ocul Surf. 2019, 17(4): 809-816. DOI: 10.1016/j.jtos.2019.02.003.
38、Gidfar S, Afsharkhamseh N, Sanjari S, et al. Notch signaling in meibomian gland epithelial cell differentiation. Invest Ophthalmol Vis Sci. 2016, 57(3): 859-865. DOI: 10.1167/iovs.15-18319.Gidfar S, Afsharkhamseh N, Sanjari S, et al. Notch signaling in meibomian gland epithelial cell differentiation. Invest Ophthalmol Vis Sci. 2016, 57(3): 859-865. DOI: 10.1167/iovs.15-18319.
39、Ding J, Sullivan DA. The effects of insulin-like growth factor 1 and growth hormone on human meibomian gland epithelial cells. JAMA Ophthalmol. 2014, 132(5): 593-599. DOI: 10.1001/jamaophthalmol.2013.8295. Ding J, Sullivan DA. The effects of insulin-like growth factor 1 and growth hormone on human meibomian gland epithelial cells. JAMA Ophthalmol. 2014, 132(5): 593-599. DOI: 10.1001/jamaophthalmol.2013.8295.
40、Braun RJ, King-Smith PE, Begley CG, et al. Dynamics and function of the tear film in relation to the blink cycle. Prog Retin Eye Res. 2015, 45: 132-164. DOI: 10.1016/j.preteyeres.2014.11.001. Braun RJ, King-Smith PE, Begley CG, et al. Dynamics and function of the tear film in relation to the blink cycle. Prog Retin Eye Res. 2015, 45: 132-164. DOI: 10.1016/j.preteyeres.2014.11.001.
41、Wang MTM, Tien L, Han A, et al. Impact of blinking on ocular surface and tear film parameters. Ocul Surf. 2018, 16(4): 424-429. DOI: 10.1016/j.jtos.2018.06.001. Wang MTM, Tien L, Han A, et al. Impact of blinking on ocular surface and tear film parameters. Ocul Surf. 2018, 16(4): 424-429. DOI: 10.1016/j.jtos.2018.06.001.
42、Nosch DS, Foppa C, Tóth M, et al. Blink animation software to improve blinking and dry eye symptoms. Optom Vis Sci. 2015, 92(9): e310-e315. DOI: 10.1097/OPX.0000000000000654. Nosch DS, Foppa C, Tóth M, et al. Blink animation software to improve blinking and dry eye symptoms. Optom Vis Sci. 2015, 92(9): e310-e315. DOI: 10.1097/OPX.0000000000000654.
43、Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017, 15(3): 438-510. DOI: 10.1016/j.jtos.2017.05.011. Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017, 15(3): 438-510. DOI: 10.1016/j.jtos.2017.05.011.
44、Wan T, Jin X, Lin L, et al. Incomplete blinking may attribute to the development of meibomian gland dysfunction. Curr Eye Res. 2016, 41(2): 179-185. DOI: 10.3109/02713683.2015.1007211.Wan T, Jin X, Lin L, et al. Incomplete blinking may attribute to the development of meibomian gland dysfunction. Curr Eye Res. 2016, 41(2): 179-185. DOI: 10.3109/02713683.2015.1007211.
45、Park J, Baek S. Dry eye syndrome in thyroid eye disease patients: the role of increased incomplete blinking and Meibomian gland loss. Acta Ophthalmol. 2019, 97(5): e800-e806. DOI: 10.1111/aos.14000. Park J, Baek S. Dry eye syndrome in thyroid eye disease patients: the role of increased incomplete blinking and Meibomian gland loss. Acta Ophthalmol. 2019, 97(5): e800-e806. DOI: 10.1111/aos.14000.
46、Fan F, Li X, Li K, et al. To find out the relationship between levels of glycosylated hemoglobin with meibomian gland dysfunction in patients with type 2 diabetes. Ther Clin Risk Manag. 2021, 17: 797-807. DOI: 10.2147/TCRM.S324423.Fan F, Li X, Li K, et al. To find out the relationship between levels of glycosylated hemoglobin with meibomian gland dysfunction in patients with type 2 diabetes. Ther Clin Risk Manag. 2021, 17: 797-807. DOI: 10.2147/TCRM.S324423.
47、Amano S, Inoue K. Clinic-based study on meibomian gland dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017, 58(2): 1283-1287. DOI: 10.1167/iovs.16-21374. Amano S, Inoue K. Clinic-based study on meibomian gland dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017, 58(2): 1283-1287. DOI: 10.1167/iovs.16-21374.
48、raig JP, Lim J, Han A, et al. Ethnic differences between the Asian and Caucasian ocular surface: a co-located adult migrant population cohort study. Ocul Surf. 2019, 17(1): 83-88. DOI: 10.1016/j.jtos.2018.09.005.raig JP, Lim J, Han A, et al. Ethnic differences between the Asian and Caucasian ocular surface: a co-located adult migrant population cohort study. Ocul Surf. 2019, 17(1): 83-88. DOI: 10.1016/j.jtos.2018.09.005.
49、Jeong S, Lemke BN, Dortzbach RK, et al. The Asian upper eyelid: an anatomical study with comparison to the Caucasian eyelid. Arch Ophthalmol. 1999, 117(7): 907-912. DOI: 10.1001/archopht.117.7.907.Jeong S, Lemke BN, Dortzbach RK, et al. The Asian upper eyelid: an anatomical study with comparison to the Caucasian eyelid. Arch Ophthalmol. 1999, 117(7): 907-912. DOI: 10.1001/archopht.117.7.907.
50、Cho M, Glavas IP. Anatomic properties of the upper eyelid in Asian Americans. Dermatol Surg. 2009, 35(11): 1736-1740. DOI: 10.1111/j.1524-4725.2009.01285.x. Cho M, Glavas IP. Anatomic properties of the upper eyelid in Asian Americans. Dermatol Surg. 2009, 35(11): 1736-1740. DOI: 10.1111/j.1524-4725.2009.01285.x.
51、Craig JP, Wang MTM, Kim D, et al. Exploring the predisposition of the Asian eye to development of dry eye. Ocul Surf. 2016, 14(3): 385-392. DOI: 10.1016/j.jtos.2016.03.002.Craig JP, Wang MTM, Kim D, et al. Exploring the predisposition of the Asian eye to development of dry eye. Ocul Surf. 2016, 14(3): 385-392. DOI: 10.1016/j.jtos.2016.03.002.
52、Kim JS, Wang MTM, Craig JP. Exploring the Asian ethnic predisposition to dry eye disease in a pediatric population. Ocul Surf. 2019, 17(1): 70-77. DOI: 10.1016/j.jtos.2018.09.003.Kim JS, Wang MTM, Craig JP. Exploring the Asian ethnic predisposition to dry eye disease in a pediatric population. Ocul Surf. 2019, 17(1): 70-77. DOI: 10.1016/j.jtos.2018.09.003.
53、Bailey RL, Gahche JJ, Miller PE, et al. Why US adults use dietary supplements. JAMA Intern Med. 2013, 173(5): 355-361. DOI: 10.1001/jamainternmed.2013.2299. Bailey RL, Gahche JJ, Miller PE, et al. Why US adults use dietary supplements. JAMA Intern Med. 2013, 173(5): 355-361. DOI: 10.1001/jamainternmed.2013.2299.
54、Kantor ED, Rehm CD, Du M, et al. Trends in dietary supplement use among US adults from 1999-2012. JAMA. 2016, 316(14): 1464-1474. DOI: 10.1001/jama.2016.14403. Kantor ED, Rehm CD, Du M, et al. Trends in dietary supplement use among US adults from 1999-2012. JAMA. 2016, 316(14): 1464-1474. DOI: 10.1001/jama.2016.14403.
55、Gong%20W%2C%20Liu%20A%2C%20Yao%20Y%2C%20et%20al.%20Nutrient%20supplement%20use%20among%20the%20Chinese%20population%3A%20a%20cross-sectional%20study%20of%20the%202010%E2%81%BB2012%20China%20nutrition%20and%20health%20surveillance.%20Nutrients.%202018%2C%2010(11)%3A%201733.%20DOI%3A%2010.3390%2Fnu10111733.%20Gong%20W%2C%20Liu%20A%2C%20Yao%20Y%2C%20et%20al.%20Nutrient%20supplement%20use%20among%20the%20Chinese%20population%3A%20a%20cross-sectional%20study%20of%20the%202010%E2%81%BB2012%20China%20nutrition%20and%20health%20surveillance.%20Nutrients.%202018%2C%2010(11)%3A%201733.%20DOI%3A%2010.3390%2Fnu10111733.%20
56、Ziemanski JF, Wolters LR, Jones-Jordan L, et al. Relation between dietary essential fatty acid intake and dry eye disease and meibomian gland dysfunction in postmenopausal women. Am J Ophthalmol. 2018, 189: 29-40. DOI: 10.1016/j.ajo.2018.01.004. Ziemanski JF, Wolters LR, Jones-Jordan L, et al. Relation between dietary essential fatty acid intake and dry eye disease and meibomian gland dysfunction in postmenopausal women. Am J Ophthalmol. 2018, 189: 29-40. DOI: 10.1016/j.ajo.2018.01.004.
57、Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc. 2008, 106: 336-356. Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc. 2008, 106: 336-356.
58、Liu Y, Kam WR, Sullivan DA. Influence of omega 3 and 6 fatty acids on human meibomian gland epithelial cells. Cornea. 2016, 35(8): 1122-1126. DOI: 10.1097/ICO.0000000000000874.Liu Y, Kam WR, Sullivan DA. Influence of omega 3 and 6 fatty acids on human meibomian gland epithelial cells. Cornea. 2016, 35(8): 1122-1126. DOI: 10.1097/ICO.0000000000000874.
59、Ole%C3%B1ik%20A%2C%20Jim%C3%A9nez-Alfaro%20I%2C%20Alejandre-Alba%20N%2C%20et%20al.%20A%20randomized%2C%20double-masked%20study%20to%20evaluate%20the%20effect%20of%20omega-3%20fatty%20acids%20supplementation%20in%20meibomian%20gland%20dysfunction.%20Clin%20Interv%20Aging.%202013%2C%208%3A%201133-1138.%20DOI%3A%2010.2147%2FCIA.S48955.%20Ole%C3%B1ik%20A%2C%20Jim%C3%A9nez-Alfaro%20I%2C%20Alejandre-Alba%20N%2C%20et%20al.%20A%20randomized%2C%20double-masked%20study%20to%20evaluate%20the%20effect%20of%20omega-3%20fatty%20acids%20supplementation%20in%20meibomian%20gland%20dysfunction.%20Clin%20Interv%20Aging.%202013%2C%208%3A%201133-1138.%20DOI%3A%2010.2147%2FCIA.S48955.%20
60、Hampel U, Krüger M, Kunnen C, et al. In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells. Exp Eye Res. 2015, 140: 139-148. DOI: 10.1016/j.exer.2015.08.024. Hampel U, Krüger M, Kunnen C, et al. In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells. Exp Eye Res. 2015, 140: 139-148. DOI: 10.1016/j.exer.2015.08.024.
61、Arita R, Itoh K, Inoue K, et al. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009, 116(3): 379-384. DOI: 10.1016/j.ophtha.2008.10.012. Arita R, Itoh K, Inoue K, et al. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009, 116(3): 379-384. DOI: 10.1016/j.ophtha.2008.10.012.
62、U%C3%A7akhan%20%C3%96%2C%20Arslanturk-Eren%20M.%20The%20role%20of%20soft%20contact%20lens%20wear%20on%20meibomian%20gland%20morphology%20and%20function.%20Eye%20Contact%20Lens.%202019%2C%2045(5)%3A%20292-300.%20DOI%3A%2010.1097%2FICL.0000000000000572.%20U%C3%A7akhan%20%C3%96%2C%20Arslanturk-Eren%20M.%20The%20role%20of%20soft%20contact%20lens%20wear%20on%20meibomian%20gland%20morphology%20and%20function.%20Eye%20Contact%20Lens.%202019%2C%2045(5)%3A%20292-300.%20DOI%3A%2010.1097%2FICL.0000000000000572.%20
63、Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol. 1981, 65(2): 108-111. DOI: 10.1136/bjo.65.2.108. Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol. 1981, 65(2): 108-111. DOI: 10.1136/bjo.65.2.108.
64、Villani E, Ceresara G, Beretta S, et al. In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci. 2011, 52(8): 5215-5219. DOI: 10.1167/iovs.11-7427.Villani E, Ceresara G, Beretta S, et al. In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci. 2011, 52(8): 5215-5219. DOI: 10.1167/iovs.11-7427.
65、Gad A, Vingrys AJ, Wong CY, et al. Tear film inflammatory cytokine upregulation in contact lens discomfort. Ocul Surf. 2019, 17(1): 89-97. DOI: 10.1016/j.jtos.2018.10.004. Gad A, Vingrys AJ, Wong CY, et al. Tear film inflammatory cytokine upregulation in contact lens discomfort. Ocul Surf. 2019, 17(1): 89-97. DOI: 10.1016/j.jtos.2018.10.004.
66、Schultz CL, Kunert KS. Interleukin-6 levels in tears of contact lens wearers. J Interferon Cytokine Res. 2000, 20(3): 309-310. DOI: 10.1089/107999000312441. Schultz CL, Kunert KS. Interleukin-6 levels in tears of contact lens wearers. J Interferon Cytokine Res. 2000, 20(3): 309-310. DOI: 10.1089/107999000312441.
67、Alghamdi W, Markoulli M, Papas E. The relationship between tear film MMP-9 and meibomian gland changes during soft contact lens wear. Cont Lens Anterior Eye. 2020, 43(2): 154-158. DOI: 10.1016/j.clae.2019.07.007.Alghamdi W, Markoulli M, Papas E. The relationship between tear film MMP-9 and meibomian gland changes during soft contact lens wear. Cont Lens Anterior Eye. 2020, 43(2): 154-158. DOI: 10.1016/j.clae.2019.07.007.
68、Alghamdi WM, Markoulli M, Holden BA, et al. Impact of duration of contact lens wear on the structure and function of the meibomian glands. Ophthalmic Physiol Opt. 2016, 36(2): 120-131. DOI: 10.1111/opo.12278. Alghamdi WM, Markoulli M, Holden BA, et al. Impact of duration of contact lens wear on the structure and function of the meibomian glands. Ophthalmic Physiol Opt. 2016, 36(2): 120-131. DOI: 10.1111/opo.12278.
69、Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol. 1982, 94(3): 383-387. DOI: 10.1016/0002-9394(82)90365-8. Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol. 1982, 94(3): 383-387. DOI: 10.1016/0002-9394(82)90365-8.
70、English FP, Nutting WB. Demodicosis of ophthalmic concern. Am J Ophthalmol. 1981, 91(3): 362-372. DOI: 10.1016/0002-9394(81)90291-9.English FP, Nutting WB. Demodicosis of ophthalmic concern. Am J Ophthalmol. 1981, 91(3): 362-372. DOI: 10.1016/0002-9394(81)90291-9.
71、Liang L, Liu Y, Ding X, et al. Significant correlation between meibomian gland dysfunction and keratitis in young patients with Demodex brevis infestation. Br J Ophthalmol. 2018, 102(8): 1098-1102. DOI: 10.1136/bjophthalmol-2017-310302. Liang L, Liu Y, Ding X, et al. Significant correlation between meibomian gland dysfunction and keratitis in young patients with Demodex brevis infestation. Br J Ophthalmol. 2018, 102(8): 1098-1102. DOI: 10.1136/bjophthalmol-2017-310302.
72、Lee SH, Chun YS, Kim JH, et al. The relationship between demodex and ocular discomfort. Invest Ophthalmol Vis Sci. 2010, 51(6): 2906-2911. DOI: 10.1167/iovs.09-4850.Lee SH, Chun YS, Kim JH, et al. The relationship between demodex and ocular discomfort. Invest Ophthalmol Vis Sci. 2010, 51(6): 2906-2911. DOI: 10.1167/iovs.09-4850.
73、Zhu M, Cheng C, Yi H, et al. Quantitative analysis of the bacteria in blepharitis with demodex infestation. Front Microbiol. 2018, 9: 1719. DOI: 10.3389/fmicb.2018.01719. Zhu M, Cheng C, Yi H, et al. Quantitative analysis of the bacteria in blepharitis with demodex infestation. Front Microbiol. 2018, 9: 1719. DOI: 10.3389/fmicb.2018.01719.
74、Lacey N, Delaney S, Kavanagh K, et al. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007, 157(3): 474-481. DOI: 10.1111/j.1365-2133.2007.08028.x. Lacey N, Delaney S, Kavanagh K, et al. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007, 157(3): 474-481. DOI: 10.1111/j.1365-2133.2007.08028.x.
75、Rabensteiner DF, Aminfar H, Boldin I, et al. Demodex mite infestation and its associations with tear film and ocular surface parameters in patients with ocular discomfort. Am J Ophthalmol. 2019, 204: 7-12. DOI: 10.1016/j.ajo.2019.03.007.Rabensteiner DF, Aminfar H, Boldin I, et al. Demodex mite infestation and its associations with tear film and ocular surface parameters in patients with ocular discomfort. Am J Ophthalmol. 2019, 204: 7-12. DOI: 10.1016/j.ajo.2019.03.007.
76、Liang L, Ding X, Tseng SCG. High prevalence of demodex brevis infestation in chalazia. Am J Ophthalmol. 2014, 157(2): 342-348.e1. DOI: 10.1016/j.ajo.2013.09.031. Liang L, Ding X, Tseng SCG. High prevalence of demodex brevis infestation in chalazia. Am J Ophthalmol. 2014, 157(2): 342-348.e1. DOI: 10.1016/j.ajo.2013.09.031.
77、Randon M, Liang H, El Hamdaoui M, et al. In vivo confocal microscopy as a novel and reliable tool for the diagnosis of Demodex eyelid infestation. Br J Ophthalmol. 2015, 99(3): 336-341. DOI: 10.1136/bjophthalmol-2014-305671.Randon M, Liang H, El Hamdaoui M, et al. In vivo confocal microscopy as a novel and reliable tool for the diagnosis of Demodex eyelid infestation. Br J Ophthalmol. 2015, 99(3): 336-341. DOI: 10.1136/bjophthalmol-2014-305671.
78、Reneker LW, Irlmeier RT, Shui YB, et al. Histopathology and selective biomarker expression in human meibomian glands. Br J Ophthalmol. 2020, 104(7): 999-1004. DOI: 10.1136/bjophthalmol-2019-314466.Reneker LW, Irlmeier RT, Shui YB, et al. Histopathology and selective biomarker expression in human meibomian glands. Br J Ophthalmol. 2020, 104(7): 999-1004. DOI: 10.1136/bjophthalmol-2019-314466.
79、Parfitt GJ, Xie Y, Geyfman M, et al. Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD). Aging. 2013, 5(11): 825-834. DOI: 10.18632/aging.100615.Parfitt GJ, Xie Y, Geyfman M, et al. Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD). Aging. 2013, 5(11): 825-834. DOI: 10.18632/aging.100615.
80、Nien CJ, Paugh JR, Massei S, et al. Age-related changes in the meibomian gland. Exp Eye Res. 2009, 89(6): 1021-1027. DOI: 10.1016/j.exer.2009.08.013. Nien CJ, Paugh JR, Massei S, et al. Age-related changes in the meibomian gland. Exp Eye Res. 2009, 89(6): 1021-1027. DOI: 10.1016/j.exer.2009.08.013.
81、Fan NW, Ho TC, Lin EH, et al. Pigment epithelium-derived factor peptide reverses mouse age-related meibomian gland atrophy. Exp Eye Res. 2019, 185: 107678. DOI: 10.1016/j.exer.2019.05.018.Fan NW, Ho TC, Lin EH, et al. Pigment epithelium-derived factor peptide reverses mouse age-related meibomian gland atrophy. Exp Eye Res. 2019, 185: 107678. DOI: 10.1016/j.exer.2019.05.018.
82、Guo Y, Zhang H, Zhao Z, et al. Hyperglycemia induces meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2022, 63(1): 30. DOI: 10.1167/iovs.63.1.30. Guo Y, Zhang H, Zhao Z, et al. Hyperglycemia induces meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2022, 63(1): 30. DOI: 10.1167/iovs.63.1.30.
83、Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015, 56(13): 7814-7820. DOI: 10.1167/iovs.15-18049.Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015, 56(13): 7814-7820. DOI: 10.1167/iovs.15-18049.
84、Sullivan BD, Evans JE, Dana MR, et al. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol. 2006, 124(9): 1286-1292. DOI: 10.1001/archopht.124.9.1286.Sullivan BD, Evans JE, Dana MR, et al. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol. 2006, 124(9): 1286-1292. DOI: 10.1001/archopht.124.9.1286.
85、Parfitt GJ, Brown DJ, Jester JV. Transcriptome analysis of aging mouse meibomian glands. Mol Vis. 2016, 22: 518-527.Parfitt GJ, Brown DJ, Jester JV. Transcriptome analysis of aging mouse meibomian glands. Mol Vis. 2016, 22: 518-527.
86、Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993, 100(3): 347-351. DOI: 10.1016/s0161-6420(93)31643-x. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993, 100(3): 347-351. DOI: 10.1016/s0161-6420(93)31643-x.
87、Reneker LW, Wang L, Irlmeier RT, et al. Fibroblast growth factor receptor 2 (FGFR2) is required for meibomian gland homeostasis in the adult mouse. Invest Ophthalmol Vis Sci. 2017, 58(5): 2638-2646. DOI: 10.1167/iovs.16-21204. Reneker LW, Wang L, Irlmeier RT, et al. Fibroblast growth factor receptor 2 (FGFR2) is required for meibomian gland homeostasis in the adult mouse. Invest Ophthalmol Vis Sci. 2017, 58(5): 2638-2646. DOI: 10.1167/iovs.16-21204.
88、Maskin SL, Tseng SC. Clonal growth and differentiation of rabbit meibomian gland epithelium in serum-free culture: differential modulation by EGF and FGF. Invest Ophthalmol Vis Sci. 1992, 33(1): 205-217.Maskin SL, Tseng SC. Clonal growth and differentiation of rabbit meibomian gland epithelium in serum-free culture: differential modulation by EGF and FGF. Invest Ophthalmol Vis Sci. 1992, 33(1): 205-217.
89、Ghosh S, O’Hare F, Lamoureux E, et al. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication. Clin Exp Ophthalmol. 2012, 40(7): 675-681. DOI: 10.1111/j.1442-9071.2012.02781.x.Ghosh S, O’Hare F, Lamoureux E, et al. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication. Clin Exp Ophthalmol. 2012, 40(7): 675-681. DOI: 10.1111/j.1442-9071.2012.02781.x.
90、Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, et al. Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea. 2016, 35(8): 1112-1116. DOI: 10.1097/ICO.0000000000000838. Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, et al. Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea. 2016, 35(8): 1112-1116. DOI: 10.1097/ICO.0000000000000838.
91、Cho WH, Lai IC, Fang PC, et al. Meibomian gland performance in glaucomatous patients with long-term instillation of IOP-lowering medications. J Glaucoma. 2018, 27(2): 176-183. DOI: 10.1097/IJG.0000000000000841.Cho WH, Lai IC, Fang PC, et al. Meibomian gland performance in glaucomatous patients with long-term instillation of IOP-lowering medications. J Glaucoma. 2018, 27(2): 176-183. DOI: 10.1097/IJG.0000000000000841.
92、Lee TH, Sung MS, Heo H, et al. Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma. PLoS One. 2018, 13(1): e0191398. DOI: 10.1371/journal.pone.0191398. Lee TH, Sung MS, Heo H, et al. Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma. PLoS One. 2018, 13(1): e0191398. DOI: 10.1371/journal.pone.0191398.
93、Agnifili L, Fasanella V, Costagliola C, et al. In vivo confocal microscopy of meibomian glands in glaucoma. Br J Ophthalmol. 2013, 97(3): 343-349. DOI: 10.1136/bjophthalmol-2012-302597. Agnifili L, Fasanella V, Costagliola C, et al. In vivo confocal microscopy of meibomian glands in glaucoma. Br J Ophthalmol. 2013, 97(3): 343-349. DOI: 10.1136/bjophthalmol-2012-302597.
94、Agnifili L, Mastropasqua R, Fasanella V, et al. Meibomian gland features and conjunctival goblet cell density in glaucomatous patients controlled with prostaglandin/timolol fixed combinations: a case control, cross-sectional study. J Glaucoma. 2018, 27(4): 364-370. DOI: 10.1097/IJG.0000000000000899. Agnifili L, Mastropasqua R, Fasanella V, et al. Meibomian gland features and conjunctival goblet cell density in glaucomatous patients controlled with prostaglandin/timolol fixed combinations: a case control, cross-sectional study. J Glaucoma. 2018, 27(4): 364-370. DOI: 10.1097/IJG.0000000000000899.
95、Mathews PM, Ramulu PY, Friedman DS, et al. Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology. 2013, 120(11): 2241-2248. DOI: 10.1016/j.ophtha.2013.03.045.Mathews PM, Ramulu PY, Friedman DS, et al. Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology. 2013, 120(11): 2241-2248. DOI: 10.1016/j.ophtha.2013.03.045.
96、Chen X, Sullivan DA, Sullivan AG, et al. Toxicity of cosmetic preservatives on human ocular surface and adnexal cells. Exp Eye Res. 2018, 170: 188-197. DOI: 10.1016/j.exer.2018.02.020. Chen X, Sullivan DA, Sullivan AG, et al. Toxicity of cosmetic preservatives on human ocular surface and adnexal cells. Exp Eye Res. 2018, 170: 188-197. DOI: 10.1016/j.exer.2018.02.020.
97、Kam%20WR%2C%20Liu%20Y%2C%20Ding%20J%2C%20et%20al.%20Do%20cyclosporine%20A%2C%20an%20IL-1%20receptor%20antagonist%2C%20uridine%20triphosphate%2C%20rebamipide%2C%20and%2For%20bimatoprost%20regulate%20human%20meibomian%20gland%20epithelial%20cells%3F%20Invest%20Ophthalmol%20Vis%20Sci.%202016%2C%2057(10)%3A%204287-4294.%20DOI%3A%2010.1167%2Fiovs.16-19937.%20Kam%20WR%2C%20Liu%20Y%2C%20Ding%20J%2C%20et%20al.%20Do%20cyclosporine%20A%2C%20an%20IL-1%20receptor%20antagonist%2C%20uridine%20triphosphate%2C%20rebamipide%2C%20and%2For%20bimatoprost%20regulate%20human%20meibomian%20gland%20epithelial%20cells%3F%20Invest%20Ophthalmol%20Vis%20Sci.%202016%2C%2057(10)%3A%204287-4294.%20DOI%3A%2010.1167%2Fiovs.16-19937.%20
98、Rath%20A%2C%20Eichhorn%20M%2C%20Tr%C3%A4ger%20K%2C%20et%20al.%20In%20vitro%20effects%20of%20benzalkonium%20chloride%20and%20prostaglandins%20on%20human%20meibomian%20gland%20epithelial%20cells.%20Ann%20Anat.%202019%2C%20222%3A%20129-138.%20DOI%3A%2010.1016%2Fj.aanat.2018.12.003.%20Rath%20A%2C%20Eichhorn%20M%2C%20Tr%C3%A4ger%20K%2C%20et%20al.%20In%20vitro%20effects%20of%20benzalkonium%20chloride%20and%20prostaglandins%20on%20human%20meibomian%20gland%20epithelial%20cells.%20Ann%20Anat.%202019%2C%20222%3A%20129-138.%20DOI%3A%2010.1016%2Fj.aanat.2018.12.003.%20
99、Zhang Y, Kam WR, Liu Y, et al. Influence of pilocarpine and timolol on human meibomian gland epithelial cells. Cornea. 2017, 36(6): 719-724. DOI: 10.1097/ICO.0000000000001181.Zhang Y, Kam WR, Liu Y, et al. Influence of pilocarpine and timolol on human meibomian gland epithelial cells. Cornea. 2017, 36(6): 719-724. DOI: 10.1097/ICO.0000000000001181.
100、Matsumoto Y, Dogru M, Sato EA, et al. S-1 induces meibomian gland dysfunction. Ophthalmology. 2010, 117(6): 1275.e4-1275.e7. DOI: 10.1016/j.ophtha.2010.01.048. Matsumoto Y, Dogru M, Sato EA, et al. S-1 induces meibomian gland dysfunction. Ophthalmology. 2010, 117(6): 1275.e4-1275.e7. DOI: 10.1016/j.ophtha.2010.01.048.
101、Chatziralli I, Sergentanis T, Zagouri F, et al. Ocular surface disease in breast cancer patients using aromatase inhibitors. Breast J. 2016, 22(5): 561-563. DOI: 10.1111/tbj.12633. Chatziralli I, Sergentanis T, Zagouri F, et al. Ocular surface disease in breast cancer patients using aromatase inhibitors. Breast J. 2016, 22(5): 561-563. DOI: 10.1111/tbj.12633.
102、Ohtomo K, Arita R, Shirakawa R, et al. Quantitative analysis of changes to meibomian gland morphology due to S-1 chemotherapy. Transl Vis Sci Technol. 2018, 7(6): 37. DOI: 10.1167/tvst.7.6.37.Ohtomo K, Arita R, Shirakawa R, et al. Quantitative analysis of changes to meibomian gland morphology due to S-1 chemotherapy. Transl Vis Sci Technol. 2018, 7(6): 37. DOI: 10.1167/tvst.7.6.37.
103、Akune Y, Yamada M, Shigeyasu C. Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. Jpn J Ophthalmol. 2018, 62(4): 432-437. DOI: 10.1007/s10384-018-0603-8. Akune Y, Yamada M, Shigeyasu C. Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. Jpn J Ophthalmol. 2018, 62(4): 432-437. DOI: 10.1007/s10384-018-0603-8.
104、Huhtala%20A%2C%20R%C3%B6nkk%C3%B6%20S%2C%20Ter%C3%A4svirta%20M%2C%20et%20al.%20The%20effects%20of%205-fluorouracil%20on%20ocular%20tissues%20in%20vitro%20and%20in%20vivo%20after%20controlled%20release%20from%20a%20multifunctional%20implant.%20Invest%20Ophthalmol%20Vis%20Sci.%202009%2C%2050(5)%3A%202216-2223.%20DOI%3A%2010.1167%2Fiovs.08-3016.%20Huhtala%20A%2C%20R%C3%B6nkk%C3%B6%20S%2C%20Ter%C3%A4svirta%20M%2C%20et%20al.%20The%20effects%20of%205-fluorouracil%20on%20ocular%20tissues%20in%20vitro%20and%20in%20vivo%20after%20controlled%20release%20from%20a%20multifunctional%20implant.%20Invest%20Ophthalmol%20Vis%20Sci.%202009%2C%2050(5)%3A%202216-2223.%20DOI%3A%2010.1167%2Fiovs.08-3016.%20
105、Eom Y, Baek S, Kim HM, et al. Meibomian gland dysfunction in patients with chemotherapy-induced lacrimal drainage obstruction. Cornea. 2017, 36(5): 572-577. DOI: 10.1097/ICO.0000000000001172. Eom Y, Baek S, Kim HM, et al. Meibomian gland dysfunction in patients with chemotherapy-induced lacrimal drainage obstruction. Cornea. 2017, 36(5): 572-577. DOI: 10.1097/ICO.0000000000001172.
106、Yin VT, Merritt HA, Sniegowski M, et al. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol. 2015, 33(2): 159-169. DOI: 10.1016/j.clindermatol.2014.10.008. Yin VT, Merritt HA, Sniegowski M, et al. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol. 2015, 33(2): 159-169. DOI: 10.1016/j.clindermatol.2014.10.008.
107、Woo YJ, Ko J, Ji YW, et al. Meibomian gland dysfunction associated with periocular radiotherapy. Cornea. 2017, 36(12): 1486-1491. DOI: 10.1097/ICO.0000000000001377. Woo YJ, Ko J, Ji YW, et al. Meibomian gland dysfunction associated with periocular radiotherapy. Cornea. 2017, 36(12): 1486-1491. DOI: 10.1097/ICO.0000000000001377.
108、Chen D, Liu X, Li Y, et al. Impact of unilateral orbital radiotherapy on the structure and function of bilateral human meibomian gland. J Ophthalmol. 2018, 2018: 9308649. DOI: 10.1155/2018/9308649.Chen D, Liu X, Li Y, et al. Impact of unilateral orbital radiotherapy on the structure and function of bilateral human meibomian gland. J Ophthalmol. 2018, 2018: 9308649. DOI: 10.1155/2018/9308649.
109、Kim SE, Yang HJ, Yang SW. Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. BMC Ophthalmol. 2020, 20(1): 24. DOI: 10.1186/s12886-019-1301-0. Kim SE, Yang HJ, Yang SW. Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. BMC Ophthalmol. 2020, 20(1): 24. DOI: 10.1186/s12886-019-1301-0.
110、Karp LA, Streeten BW, Cogan DG. Radiation-induced atrophy of the Meibomian gland. Arch Ophthalmol. 1979, 97(2): 303-305. DOI: 10.1001/archopht.1979.01020010155013. Karp LA, Streeten BW, Cogan DG. Radiation-induced atrophy of the Meibomian gland. Arch Ophthalmol. 1979, 97(2): 303-305. DOI: 10.1001/archopht.1979.01020010155013.
111、Xiao J, Adil MY, Olafsson J, et al. Diagnostic test efficacy of meibomian gland morphology and function. Sci Rep. 2019, 9(1): 17345. DOI: 10.1038/s41598-019-54013-4. Xiao J, Adil MY, Olafsson J, et al. Diagnostic test efficacy of meibomian gland morphology and function. Sci Rep. 2019, 9(1): 17345. DOI: 10.1038/s41598-019-54013-4.
112、Miyake H, Oda T, Katsuta O, et al. Meibomian gland dysfunction model in hairless mice fed a special diet with limited lipid content. Invest Ophthalmol Vis Sci. 2016, 57(7): 3268-3275. DOI: 10.1167/iovs.16-19227. Miyake H, Oda T, Katsuta O, et al. Meibomian gland dysfunction model in hairless mice fed a special diet with limited lipid content. Invest Ophthalmol Vis Sci. 2016, 57(7): 3268-3275. DOI: 10.1167/iovs.16-19227.
113、Goto E, Endo K, Suzuki A, et al. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2003, 44(2): 533-539. DOI: 10.1167/iovs.02-0170. Goto E, Endo K, Suzuki A, et al. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2003, 44(2): 533-539. DOI: 10.1167/iovs.02-0170.
114、Eom Y, Lee JS, Kang SY, et al. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. Am J Ophthalmol. 2013, 155(6): 1104-1110.e2. DOI: 10.1016/j.ajo.2013.01.008. Eom Y, Lee JS, Kang SY, et al. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. Am J Ophthalmol. 2013, 155(6): 1104-1110.e2. DOI: 10.1016/j.ajo.2013.01.008.
115、Menzies%20KL%2C%20Srinivasan%20S%2C%20Prokopich%20CL%2C%20et%20al.%20Infrared%20imaging%20of%20meibomian%20glands%20and%20evaluation%20of%20the%20lipid%20layer%20in%20Sj%C3%B6gren%E2%80%99s%20syndrome%20patients%20and%20nondry%20eye%20controls.%20Invest%20Ophthalmol%20Vis%20Sci.%202015%2C%2056(2)%3A%20836-841.%20DOI%3A%2010.1167%2Fiovs.14-13864.%20Menzies%20KL%2C%20Srinivasan%20S%2C%20Prokopich%20CL%2C%20et%20al.%20Infrared%20imaging%20of%20meibomian%20glands%20and%20evaluation%20of%20the%20lipid%20layer%20in%20Sj%C3%B6gren%E2%80%99s%20syndrome%20patients%20and%20nondry%20eye%20controls.%20Invest%20Ophthalmol%20Vis%20Sci.%202015%2C%2056(2)%3A%20836-841.%20DOI%3A%2010.1167%2Fiovs.14-13864.%20
116、Eom%20Y%2C%20Han%20JY%2C%20Kang%20B%2C%20et%20al.%20Meibomian%20Glands%20and%20Ocular%20Surface%20Changes%20After%20Closure%20of%20Meibomian%20Gland%20Orifices%20in%20Rabbits.%20Cornea.%202018%2C%2037(2)%3A218-226.%20DOI%3A%2010.1097%2FICO.0000000000001460.%C2%A0Eom%20Y%2C%20Han%20JY%2C%20Kang%20B%2C%20et%20al.%20Meibomian%20Glands%20and%20Ocular%20Surface%20Changes%20After%20Closure%20of%20Meibomian%20Gland%20Orifices%20in%20Rabbits.%20Cornea.%202018%2C%2037(2)%3A218-226.%20DOI%3A%2010.1097%2FICO.0000000000001460.%C2%A0
117、Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf, 2019, 17(1): 104-110. DOI: 10.1016/j.jtos.2018.11.004. Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf, 2019, 17(1): 104-110. DOI: 10.1016/j.jtos.2018.11.004.
118、Song P, Sun Z, Ren S, et al. Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery: a prospective, randomized clinical trial. Biomed Res Int. 2019, 2019: 2737968. DOI: 10.1155/2019/2737968. Song P, Sun Z, Ren S, et al. Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery: a prospective, randomized clinical trial. Biomed Res Int. 2019, 2019: 2737968. DOI: 10.1155/2019/2737968.
119、Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2018, 102(1): 59-68. DOI: 10.1136/bjophthalmol-2016-310097. Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2018, 102(1): 59-68. DOI: 10.1136/bjophthalmol-2016-310097.